MedWatch

Lundbeck ties bank loans to sustainability targets

How much the pharmaceutical firm has to pay in interest on its EUR 1.5bn bank loans will now depend on its sustainability performance.

Lundbeck is coupling its loan interest rates to its sustainability performance | Photo: Lundbeck / PR

In a first for Lundbeck, the pharmaceutical firm has tied its interest rate on a number of bank loans to its sustainability targets, an email sent to MedWatch announces.

Lundbeck says that the cobbling of sustainability targets to loans will apply to its existing credit facility of EUR 1.5bn, which includes its banking group of Danske Bank, Jyske Bank, Nordea, Bank of America Europe, and a number of other international financial institutions.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

FDA fast-tracks Eli Lilly's obesity candidate

Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.

Jefferies spots weaknesses in GN

One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.

Further reading

Related articles

Latest news

See all jobs